Cargando…
Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients
BACKGROUND: Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or rep...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265302/ https://www.ncbi.nlm.nih.gov/pubmed/18221530 http://dx.doi.org/10.1186/1742-4690-5-7 |
_version_ | 1782151468305874944 |
---|---|
author | Kapoor, Amit Shapiro, Beth Shafer, Robert W Shulman, Nancy Rhee, Soo-Yon Delwart, Eric L |
author_facet | Kapoor, Amit Shapiro, Beth Shafer, Robert W Shulman, Nancy Rhee, Soo-Yon Delwart, Eric L |
author_sort | Kapoor, Amit |
collection | PubMed |
description | BACKGROUND: Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or repeatedly on different HIV genetic backbones during the course of failed anti-viral therapies we analyzed a linked region of the viral genome during the evolution of multi-drug resistance. RESULTS: Using L90M allele specific PCR we amplified and sequenced gag-pro regions linked to very early L90M containing HIV variants prior to their emergence and detection as dominant viruses in 15 failed salvage therapy patients. The early minority L90M linked sequences were then compared to those of the later L90M viruses that came to dominate the plasma quasispecies. Using Bayesian evolutionary analysis sampling trees the emergence of L90M containing viruses was seen to take place on multiple occasion in 5 patients, only once for 2 patients and an undetermined number of time for the remaining 8 patients. CONCLUSION: These results indicate that early L90M mutants can frequently be displaced by viruses carrying independently selected L90M mutations rather than by descendents of the earlier mutants. |
format | Text |
id | pubmed-2265302 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22653022008-03-07 Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients Kapoor, Amit Shapiro, Beth Shafer, Robert W Shulman, Nancy Rhee, Soo-Yon Delwart, Eric L Retrovirology Research BACKGROUND: Combination anti-viral therapies have reduced treatment failure rates by requiring multiple specific mutations to be selected on the same viral genome to impart high-level drug resistance. To determine if the common protease inhibitor resistance mutation L90M is only selected once or repeatedly on different HIV genetic backbones during the course of failed anti-viral therapies we analyzed a linked region of the viral genome during the evolution of multi-drug resistance. RESULTS: Using L90M allele specific PCR we amplified and sequenced gag-pro regions linked to very early L90M containing HIV variants prior to their emergence and detection as dominant viruses in 15 failed salvage therapy patients. The early minority L90M linked sequences were then compared to those of the later L90M viruses that came to dominate the plasma quasispecies. Using Bayesian evolutionary analysis sampling trees the emergence of L90M containing viruses was seen to take place on multiple occasion in 5 patients, only once for 2 patients and an undetermined number of time for the remaining 8 patients. CONCLUSION: These results indicate that early L90M mutants can frequently be displaced by viruses carrying independently selected L90M mutations rather than by descendents of the earlier mutants. BioMed Central 2008-01-25 /pmc/articles/PMC2265302/ /pubmed/18221530 http://dx.doi.org/10.1186/1742-4690-5-7 Text en Copyright © 2008 Kapoor et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Kapoor, Amit Shapiro, Beth Shafer, Robert W Shulman, Nancy Rhee, Soo-Yon Delwart, Eric L Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
title | Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
title_full | Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
title_fullStr | Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
title_full_unstemmed | Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
title_short | Multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
title_sort | multiple independent origins of a protease inhibitor resistance mutation in salvage therapy patients |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265302/ https://www.ncbi.nlm.nih.gov/pubmed/18221530 http://dx.doi.org/10.1186/1742-4690-5-7 |
work_keys_str_mv | AT kapooramit multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients AT shapirobeth multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients AT shaferrobertw multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients AT shulmannancy multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients AT rheesooyon multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients AT delwartericl multipleindependentoriginsofaproteaseinhibitorresistancemutationinsalvagetherapypatients |